Diflucan Lawsuits

Side effects of Diflucan (fluconazole) when used during pregnancy may increase the risk of children being born with serious birth defects, such as cleft palate or lip; head, bone or joint defects; and congenital heart defects.

DIFLUCAN LAWSUIT STATUS: Lawyers are reviewing potential claims for children who may be entitled to compensation through a Diflucan birth defect lawsuit as a result of the drug maker’s failure to warn about the risks associated with the use of this medication during pregnancy.


Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

OVERVIEW: Diflucan (fluconazole) is manufactured by Pfizer, but generic Diflucan is available from a number of drug makers. The medication is used to treat yeast infections and some types of meningitis. It is available in tablet form, for oral suspension and as an injection.

Use of high doses of Diflucan during pregnancy (400-800mg daily doses) have been linked to a rare and distinct set of birth defects, including:

  • Head Defects (also known as flat head syndrome or brachycephaly)
  • Abnormal Face Development
  • Abnormal Skull Development
  • Cleft Palate or Cleft Lip
  • Femoral Bowing or Bent Thigh Bones
  • Thin Ribs and Long Bones
  • Muscle Weakness and Joint Deformities (Arthrogyposis)
  • Congenital Heart Disease

DIFLUCAN BIRTH DEFECT SIDE EFFECTS: In August 2011, the FDA issued new warnings about the risk of birth defects from Diflucan when high doses of the medication are used during the first trimester of pregnancy. Pregnancy Diflucan use at 400-800mg daily doses may increase the risk of these rare and distinct set of birth defect side effects.

Although the FDA did not issue a Diflucan recall, the agency reclassified 400-800 mg Diflucan doses from a category C pregnancy drug to a category D drug, meaning that the FDA considers it a risk to the human fetus, but that risk may be acceptable in some cases due to the potential life-saving benefit to the mother. The same warnings were not applied to single 150mg dose treatments typically used to treat yeast infections, but that low-dose version does remain a category C drug, due to some evidence of fetal harm in animal studies.

Multiple case reports have described similar, rare and distinct congential anomalies in children born to mothers who used chronic high-dose fluconazole treatment for meningitis or yeast infections. The combination of fluconazole birth defects seen rarely occur in the general population.

LAWYERS FOR DIFLUCAN LAWSUITS: Potential claims are being reviewed for children throughout the United States by Diflucan birth defect lawyers.

To have a potential claim reviewed and evaluated, request a free consultation and claim evaluation.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024
Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024 (Posted 4 days ago)

With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.